Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.50
Bid: 107.00
Ask: 110.00
Change: 6.00 (5.85%)
Spread: 3.00 (2.804%)
Open: 102.50
High: 108.50
Low: 102.50
Prev. Close: 102.50
TRT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Repurchase Programme

22 Feb 2022 07:01

RNS Number : 3474C
Transense Technologies PLC
22 February 2022
 

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation 596/2014/EU (which is part of UK law by virtue of the European Union (Withdrawal) Act 2018)

 

 

Transense Technologies plc

("Transense" or "the Company")

 

Share Repurchase Programme

 

Transense Technologies plc (AIM: TRT), the developer of specialist sensor systems, is pleased to announce that it will commence a programme to conduct market purchases of ordinary shares of 10 pence each in the Company ("Ordinary Shares") up to a maximum aggregate purchase price of £300,000 (the "Programme").

 

The Company has entered into an arrangement with Shard Capital Stockbrokers ("Shard") in relation to the Programme where Shard will make the trading decisions concerning the timing of the market purchases of Ordinary Shares independently of and uninfluenced by the Company, with such trading decisions being in accordance with the terms of the Programme. Purchases may continue during any periods during the term of the Programme when the Company itself would be prohibited from dealing by the UK version of the Market Abuse Regulation 596/2014/EU (which is part of UK law by virtue of the European Union (Withdrawal) Act 2018) ("UK MAR"). The Company reserves the right to terminate the programme if at any time it deems this to be appropriate and would make an announcement in advance of so doing.

 

The Company confirms that it currently has no unpublished inside information.

 

The Programme will commence today, 22 February 2022, and will continue until 31 October 2022 unless terminated earlier.

 

The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on 23 November 2021 to purchase up to 1,643,774 Ordinary Shares. This authority will expire at the earlier of the end of the next Annual General Meeting of the Company or 23 February 2024.

 

Any market purchases will be conducted in compliance with the following restrictions regarding price conditions:  

· the minimum price (exclusive of any expenses) at which any Ordinary Share may be purchased shall be its nominal value of 10 pence

· the maximum price (exclusive of any expenses) at which any Ordinary Share may be purchased shall be the higher of: (i) an amount equal to 5 per cent, above the average of the middle market quotations of an Ordinary Share as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the date of such purchase, and (ii) the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out.

 

Due to the limited liquidity in the Ordinary Shares, any market purchase of Ordinary Shares pursuant to the Programme on any trading day could represent a significant proportion of the daily trading volume in the Ordinary Shares on AIM and could exceed 25 per cent. of the average daily trading volume. This means that the Company will not benefit from the exemption contained in Article 5(1) of UK MAR.

 

The objective of the Programme is to offset the dilutive impact of share awards to directors and employees.

 

Ordinary Shares acquired as a result of the Programme will be held by the Company in treasury and in accordance with the Companies Act 2006, will not have any voting rights. It is anticipated that any Ordinary Shares held in treasury but surplus to unexercised option requirements from time to time will be cancelled.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Nicholas Johnson

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

 

Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

· SAW, patent protected Surface Acoustic Wave sensor technology that provides real time measurement of torque, temperature, pressure and strain, that is used to improve efficiency, performance and safety of propulsion systems and machinery;

· Translogik, smart, connected commercial vehicle tyre inspection equipment, used by vehicle fleets to more easily gather and maintain accurate tyre safety and condition data; and

· iTrack, a tyre pressure monitoring system for off-highway machinery, licensed exclusively to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal.

Target market sectors include automotive, aerospace and industrial machinery. The Group's strategy is to leverage excellence in innovation, know-how in wireless sensor technologies and form industry partnerships in these global growth sectors to maximise shareholder value through sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999.

For further information please contact transense@walbrookpr.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKFLFLLLLEBBK
Date   Source Headline
25th Jun 20188:29 amRNSHolding(s) in Company
21st Jun 20182:33 pmRNSResult of General Meeting
31st May 20187:00 amRNSPlacing and Notice of General Meeting
8th May 20187:00 amRNSNew Translogik iTrack Contract Win
2nd Mar 201812:26 pmRNSStatement re joint broker
7th Feb 20187:00 amRNSInterim Results
5th Feb 20189:56 amRNSHolding(s) in Company
21st Dec 20171:09 pmRNSResult of AGM
21st Dec 20177:00 amRNSAGM Statement
18th Dec 201711:18 amRNSIssue of Equity
27th Nov 20179:29 amRNSContract Win
14th Nov 20177:00 amRNSNotice of AGM
26th Sep 20177:00 amRNSFinal Results
5th Sep 20177:00 amRNSNotice of Results
5th Sep 20177:00 amRNSInvestor Event
7th Aug 20177:00 amRNSNew iTrack Contract Win with BHP in Australia
31st Jul 20177:00 amRNSTrading Update
27th Jun 20177:00 amRNSAward of options
26th Jun 20177:00 amRNSGlencore - Further Contract Win
6th Jun 20177:00 amRNSDirector/PDMR Shareholding
5th Jun 20177:00 amRNSGlencore - Further Contract Win
4th Apr 20175:20 pmRNSHolding(s) in Company
29th Mar 20177:01 amRNSInterim results
29th Mar 20177:00 amRNSFurther Payment from General Electric
1st Mar 20177:00 amRNSInvestor Event
28th Feb 20171:54 pmRNSNotice of Results
27th Jan 20177:00 amRNSIssue of Equity
22nd Dec 20168:19 amRNSCapital Reduction
23rd Nov 20163:45 pmRNSResult of AGM & Share Consolidation
23rd Nov 20167:00 amRNSAGM Statement
21st Sep 20167:00 amRNSNotice of AGM
21st Sep 20167:00 amRNSFinal Results
25th Aug 20167:00 amRNSInvestor Event
16th Aug 20167:00 amRNSNotice of Results
18th Jul 20167:01 amRNSTrading Update
18th Jul 20167:00 amRNSLicence Agreement with GE
9th Mar 20162:55 pmRNSHolding(s) in Company
2nd Mar 20167:00 amRNSInterim Results
16th Dec 20157:00 amRNSTranslogik Contract Win with Continental
16th Nov 20153:55 pmRNSResult of AGM
16th Nov 20157:00 amRNSAGM Statement
22nd Oct 20157:00 amRNSDirector Dealing
21st Oct 20157:00 amRNSSale of IntelliSAW Division for US$5m
8th Oct 20157:00 amRNSNotice of AGM and Posting of Accounts
28th Sep 20157:00 amRNSPreliminary unaudited results
13th Aug 20157:00 amRNSNew Translogik iTrack Contract Win
29th Jul 201512:36 pmRNSHolding(s) in Company
27th Jul 20151:30 pmRNSResult of General Meeting
27th Jul 20157:00 amRNSGM Statement & Result of Offer for Subscription
16th Jul 20157:00 amRNSRe: Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.